How long will this process take? After rereading the Dec 19 update, it’s a strong possibility that it is still a bit of a wait.
In the announcement Dr T says that “in recent weeks the process has advanced further “. So we may have only started serious negotiations in November?.
The process started back at the start of 2019, the negotiations only became meaningful in November.
The old adage “ No news is good news” might bear fruit for us. We have now had 3 months of these meaningful and appropriate discussions. So as of today they are continuing. Three months would be enough time for the negotiating parties to get a good idea if they are close enough to closing any gaps.
Still looking good for a deal. ACAD may be waiting to see whom they are bidding against and how much they need pay to win here.
- Forums
- ASX - By Stock
- NEU
- How long?.
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.56%
!
$14.28

How long?.
-
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.28 |
Change
0.080(0.56%) |
Mkt cap ! $1.777B |
Open | High | Low | Value | Volume |
$14.22 | $14.55 | $14.10 | $4.611M | 320.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6352 | $14.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.38 | 4000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2012 | 14.070 |
1 | 740 | 14.060 |
2 | 437 | 14.000 |
1 | 2000 | 13.920 |
1 | 720 | 13.880 |
Price($) | Vol. | No. |
---|---|---|
14.380 | 4000 | 1 |
14.400 | 3000 | 1 |
14.450 | 9123 | 1 |
14.500 | 200 | 1 |
14.580 | 3131 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online